Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
18.45
+0.01 (+0.05%)
Official Closing Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries ADR
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Teva Pharmaceutical Lifts Revenue Forecast - Huntington's And Migraine Drugs Help Q3 Performance
November 08, 2023
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) reported Q3 sales of $3.85 billion, beating the consensus of $3.72 billion
Via
Benzinga
Teva Closes In On A Buy Point On Third-Quarter Beat, Business Separation
November 08, 2023
The company named a new chief executive for its Teva api business.
Via
Investor's Business Daily
US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings
November 08, 2023
Stock futures indicate a subdued opening on Wednesday after several consecutive gains in major averages. Traders are eagerly awaiting Federal Reserve Chair Jerome Powell’s speech for insights into...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
November 08, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Earnings Scheduled For November 8, 2023
November 08, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Via
Benzinga
Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business
November 07, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva to Present New Data Supporting Safety, Efficacy and Real-World Effectiveness of AUSTEDO® (deutetrabenazine) Tablets at the 2023 HSG Annual Meeting
November 02, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry
November 01, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook
October 25, 2023
Alkermes PLC (NASDAQ: ALKS) reported Q3 FY23 adjusted EPS of $0.64 compared to $0.02 a year ago, beating the
Via
Benzinga
Teva to Provide Second Round of Funding to Clinics in California, Florida and New Jersey as Part of $2 Million Commitment Through Community Routes: Access to Mental Health Care Program
October 25, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space
October 23, 2023
Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases.
Via
Investor's Business Daily
Israeli-Hamas War: U.S. Exchange-Listed Israeli Stocks Continue To Decline
October 22, 2023
The 111 Israeli companies with stocks trading on US exchanges have combined market caps over $150B. Or at least they did midweek: since the Hamas-Israeli War began October 7th, pretty much everything...
Via
Talk Markets
Investor Exit Israel ETFs Following Attacks, But Remain Confident In Large-Caps
October 19, 2023
Israel-focused ETFs have plunged since the last trading day before Hamas launched surprise attacks on Israel, while some Israeli companies listed in the U.S. have so far escaped repercussions to their...
Via
Benzinga
Topics
ETFs
Thoughts For Thursday: War Worries Rattle The Market
October 19, 2023
Via
Talk Markets
Hamas-Israeli War: US Exchange Listed Israeli Stocks Hit Hard
October 18, 2023
111 Israeli companies trade on U.S. stock exchanges of which only 15 have market capitalization of $2B or more.
Via
Talk Markets
Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder
October 17, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Israel Could Form Emergency Government: Defense Stocks, Israel ETFs In Focus During Conflict
October 10, 2023
As Israel ramps up its armed forces and a regional war with Hamas enters its fourth day, the country is considering forming an emergency government.
Via
Benzinga
Topics
ETFs
Israeli Stocks Fall as Investors Fear Middle East Conflict
October 09, 2023
The recent attacks on Israel will have a lasting economic impact. Here's what investors should know about Israeli stocks.
Via
InvestorPlace
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
October 09, 2023
Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil.
Via
Benzinga
Topics
ETFs
Why Teva Pharmaceutical (TEVA) Stock Is Falling
October 09, 2023
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares are trading lower by 2.7% to $9.17 Monday morning amid conflict in the company's home country, Israel.
Via
Benzinga
Middle East War Hammers Israel-Based Stocks But Lifts Defense, Oil Names
October 09, 2023
Israel stocks, regardless of industry, sank Monday following the terrorist attack on Israel.
Via
Investor's Business Daily
Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023
October 06, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories
October 04, 2023
Benzinga
Via
Benzinga
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
October 04, 2023
The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck.
Via
Investor's Business Daily
Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People
October 04, 2023
Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and
Via
Benzinga
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
October 04, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
Teva Announces Changes to Executive Management Team
September 28, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
September 27, 2023
A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co (NYSE: LLY). T
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.